# Safety & Tolerability of Hypertonic Saline Administration Via Intraosseous Access

> **NCT03276494** · PHASE2 · COMPLETED · sponsor: **Ohio State University** · enrollment: 6 (actual)

## Conditions studied

- Stroke
- Intracranial Hypotension
- Cerebral Edema

## Interventions

- **DEVICE:** Intraosseous
- **DRUG:** Hypertonic saline

## Key facts

- **NCT ID:** NCT03276494
- **Lead sponsor:** Ohio State University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-21
- **Primary completion:** 2018-04-21
- **Final completion:** 2018-04-21
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2019-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03276494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03276494, "Safety & Tolerability of Hypertonic Saline Administration Via Intraosseous Access". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03276494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*